Citations (127)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Jin Chen, Min Gong, Zhuo Huang, Fang Wang, Yajing Wang, Zuquan Hu, Zhu Zeng & Yun Wang. (2022) Alleviating Aspirin-Induced Gastric Injury by Binding Aspirin to β-Lactoglobulin. Drug Design, Development and Therapy 16, pages 571-586.
Read now
Read now
Hanan Muzeyin Kedir, Eskinder Ayalew Sisay & Alfoalem Araba Abiye. (2021) Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review. International Journal of General Medicine 14, pages 4757-4763.
Read now
Read now
Tzu-Min Lin, Jia-En Chi, Chi-Ching Chang & Yi-No Kang. (2019) Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials. Journal of Pain Research 12, pages 83-91.
Read now
Read now
Guillermo García-Rayado, Carlos Sostres & Angel Lanas. (2017) Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. Expert Review of Clinical Pharmacology 10:8, pages 875-888.
Read now
Read now
Byron Cryer & Kenneth W Mahaffey. (2014) Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment. Journal of Multidisciplinary Healthcare 7, pages 137-146.
Read now
Read now
Danielle Duffy, Erik Kelly, Amanda Trang, David Whellan & Geoffrey Mills. (2014) Aspirin for Cardioprotection and Strategies to Improve Patient Adherence. Postgraduate Medicine 126:1, pages 18-28.
Read now
Read now
Katelyn W Sylvester, Judy WM Cheng & Mandeep R Mehra. (2013) Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events. Vascular Health and Risk Management 9, pages 245-254.
Read now
Read now
Hussam M Tayeb, Adam J Nelson, Scott R Willoughby & Matthew I Worthley. (2011) Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes. Patient Related Outcome Measures 2, pages 7-19.
Read now
Read now
Paola Patrignani, Stefania Tacconelli, Annalisa Bruno, Carlos Sostres & Angel Lanas. (2011) Managing the adverse effects of nonsteroidal anti-inflammatory drugs. Expert Review of Clinical Pharmacology 4:5, pages 605-621.
Read now
Read now
Angel Lanas. (2011) Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice. Expert Opinion on Drug Safety 10:1, pages 45-54.
Read now
Read now
Kåre E Bakkevold. (2010) Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985–2008. Clinical and Experimental Gastroenterology 3, pages 71-77.
Read now
Read now
Harald Vonkeman, Inger Meek & Mart van de Laar. (2010) Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin. Drug, Healthcare and Patient Safety 2, pages 191-204.
Read now
Read now
Neville D. Yeomans, Christopher J. Hawkey, Wayne Brailsford & Jørgen Næsdal. (2009) Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs. Current Medical Research and Opinion 25:11, pages 2785-2793.
Read now
Read now
Thomas Wex, Doerthe Kuester, Michael Vieth, Gerhard Treiber, Anja Krieg, Albert Roessner & Peter Malfertheiner. (2008) Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (α1-PI) levels in antral mucosa and peripheral blood. Scandinavian Journal of Gastroenterology 43:10, pages 1194-1201.
Read now
Read now
Articles from other publishers (113)
Priya Bindal, Vishal Kumar, Lakshay Kapil, Charan Singh & Arti Singh. (2023) Therapeutic management of ischemic stroke. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Crossref
Yoshikazu Kinoshita, Mototsugu Kato, Katsuya Sugizaki & Satoshi Ikeuchi. (2023) Rabeprazole Coadministration Controls Ulcer Recurrence in Patients on Low-dose Aspirin Therapy: A Multicenter Prospective Study. Internal Medicine 62:4, pages 495-502.
Crossref
Crossref
H.B. Costa-Filho, T.M.A.L. Sales, S.M. Paula, L.A.D. Nicolau, M.L. Queiroga, A. Havt, P.M.G. Soares, A.L.R. Barbosa & M.H.L.P. Souza. (2023) Role of cyclooxygenases 1 and 2 in the maintenance of colonic mucosal integrity in an experimental colitis model. Brazilian Journal of Medical and Biological Research 56.
Crossref
Crossref
Kelly E. Lloyd, Robbie Foy, Louise H. Hall, Lucy Ziegler, Sophie M. C. Green, Zainab F. Haider, David G. Taylor, Mairead MacKenzie & Samuel G. Smith. (2022) Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providers. Hereditary Cancer in Clinical Practice 20:1.
Crossref
Crossref
Kelly E. Lloyd, Louise H. Hall, Natalie King, Rachael J. Thorneloe, Rocio Rodriguez-Lopez, Lucy Ziegler, David G. Taylor, Mairead MacKenzie & Samuel G. Smith. (2022) Aspirin use for cancer prevention: A systematic review of public, patient and healthcare provider attitudes and adherence behaviours. Preventive Medicine 154, pages 106872.
Crossref
Crossref
C. J. Borgert, C. Fuentes & L. D. Burgoon. (2021) Principles of dose-setting in toxicology studies: the importance of kinetics for ensuring human safety. Archives of Toxicology 95:12, pages 3651-3664.
Crossref
Crossref
Marcela Forgerini, Gustavo Urbano, Tales Rubens de Nadai, Sabrina Setembre Batah, Alexandre Todorovic Fabro & Patrícia de Carvalho Mastroianni. (2021) Genetic Variants in PTGS1 and NOS3 Genes Increase the Risk of Upper Gastrointestinal Bleeding: A Case–Control Study. Frontiers in Pharmacology 12.
Crossref
Crossref
Donald J. AbrahamSamuel Chackalamannil. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
70
.
Toshihiko Kakiuchi, Takashi Kumamoto, Azusa Koji & Muneaki Matsuo. (2021) Low‐dose aspirin‐induced gastric mucosal injury after Fontan surgery in an adolescent. Clinical Case Reports 9:4, pages 2460-2464.
Crossref
Crossref
Lin Zheng, Weibiao Lv, Yuanqing Zhou, Xu Lin & Jie Yao. (2020) Progress on the Mechanism for Aspirin’s Anti-tumor Effects. Current Drug Targets 22:1, pages 105-111.
Crossref
Crossref
Zhuoya Li, Zheng Wang, Baile Shen, Chen Chen, Xiaoyun Ding & Haojun Song. (2020) Effects of aspirin on the gastrointestinal tract: Pros vs. cons (Review). Oncology Letters 20:3, pages 2567-2578.
Crossref
Crossref
Junichi Iwamoto, Masashi Murakami, Tadakuni Monma, Hajime Ueda, Makoto Tamamushi, Naoki Konishi, Sho-ichiro Yara, Takeshi Hirayama, Tadashi Ikegami, Akira Honda & Yuji Mizokami. (2020) Current states of prevention of drug-induced gastroduodenal ulcer in real clinical practice: a cross-sectional study. Journal of Clinical Biochemistry and Nutrition 66:2, pages 158-162.
Crossref
Crossref
Marjorie M. Walker & Nicholas J. Talley. (2019) Functional Dyspepsia in the Elderly. Current Gastroenterology Reports 21:10.
Crossref
Crossref
Emma Leitinger, Lisa Hui & Andrew Grigg. (2019) Is there a role for proton pump inhibitor prophylaxis in haematology patients?. Internal Medicine Journal 49:6, pages 694-701.
Crossref
Crossref
Zongliang Xu, Huamei Wang, Ying Lin, Qijin Zhai, Wen Sun, Zhaojun Wang, Zusen Ye, Hao Zhang, Shenghua Li, Kunxiong Yuan, Xinfeng Liu, Junrong Li & Gelin Xu. (2019) The Impacts of Peptic Ulcer on Functional Outcomes of Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 28:2, pages 311-316.
Crossref
Crossref
Pei-Jui Luo, Xi-Hsuan Lin, Chung-Chi Lin, Jiing-Chyuan Luo, Hsiao-Yun Hu, Po-Hsiang Ting & Ming-Chih Hou. (2018) Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study. Journal of the Formosan Medical Association.
Crossref
Crossref
Koh Fukushi, Keiichi Tominaga, Kazunori Nagashima, Akira Kanamori, Naoya Izawa, Mimari Kanazawa, Takako Sasai & Hideyuki Hiraishi. (2018) Gastroduodenal ulcer bleeding in elderly patients on low dose aspirin therapy. World Journal of Gastroenterology 24:34, pages 3908-3918.
Crossref
Crossref
Amie Bain. (2018) Antiplatelet use in practice. British Journal of Cardiac Nursing 13:6, pages 272-278.
Crossref
Crossref
Tejas K. Patel & Parvati B. Patel. (2018) Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis. European Journal of Clinical Pharmacology 74:6, pages 819-832.
Crossref
Crossref
Tian-Yu Chi, Hong-Ming Zhu & Mei Zhang. (2018) Risk factors associated with nonsteroidal anti-inflammatory drugs (NSAIDs)-induced gastrointestinal bleeding resulting on people over 60 years old in Beijing. Medicine 97:18, pages e0665.
Crossref
Crossref
Jing-Yuan Fang, Yi Qi Du, Wen Zhong Liu, Jian Lin Ren, Yan Qing Li, Xiao Yu Chen, Nong Hua Lv, Ying Xuan Chen & Bin Lv. (2018) Chinese consensus on chronic gastritis (2017, Shanghai). Journal of Digestive Diseases 19:4, pages 182-203.
Crossref
Crossref
Jing Shan, Hongjun Lei, Wei Shi, Xiaobin Sun, Yu Tang & Chunrong Ren. (2018) High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury. Digestive Diseases 36:1, pages 66-71.
Crossref
Crossref
Serdar Farhan, Usman Baber & Roxana Mehran. 2018. The Interventional Cardiology Training Manual. The Interventional Cardiology Training Manual
503
522
.
Anca Negovan, Mihaela Iancu, Valeriu Moldovan, Kinga Sàrkàny, Simona Bataga, Simona Mocan, Ioan Țilea & Claudia Banescu. (2017) The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy. European Journal of Internal Medicine 44, pages 62-66.
Crossref
Crossref
Sang Min Park, Haemin Jeong, Mi-Hyang Jung, Kyung Soon Hong, Myeong-Ki Hong, Chang Seok Bang & Christopher Y. Kim. (2017) Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial. Contemporary Clinical Trials 60, pages 51-55.
Crossref
Crossref
Jae Hee Cho, Ja Sung Choi, Song Wook Chun, Sangheun Lee, Ki Jun Han & Hee Man Kim. (2016) The IL-1B Genetic Polymorphism Is Associated with Aspirin-Induced PepticUlcers in a Korean Ethnic Group. Gut and Liver 10:3.
Crossref
Crossref
Michael E. Farkouh. (2016) A COGENT Argument for Gastrointestinal Protection With Low-Dose Aspirin ∗. Journal of the American College of Cardiology 67:14, pages 1672-1673.
Crossref
Crossref
Anca Negovan, Mihaela Iancu, Valeriu Moldovan, Septimiu Voidazan, Simona Bataga, Monica Pantea, Kinga Sarkany, Cristina Tatar, Simona Mocan & Claudia Banescu. (2016) Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin Consumers. Gastroenterology Research and Practice 2016, pages 1-8.
Crossref
Crossref
Katsunori Iijima. 2016. NSAIDs and Aspirin. NSAIDs and Aspirin
143
152
.
Ana M. Sahagún, José Vaquera, Juan J. García, Ángela P. Calle, María-José Diez, Nélida Fernández, Juan F. Loro, Hugo O. Portilla & Matilde Sierra. (2015) Study of the protective effect on intestinal mucosa of the hydrosoluble fiber Plantago ovata husk. BMC Complementary and Alternative Medicine 15:1.
Crossref
Crossref
Kazumasa Miyake, Teppei Akimoto, Yuriko Hanada, Hiroyuki Nagoya, Yasuhiro Kodaka, Nobue Ueki, Masafumi Kusunoki, Tetsuro Kawagoe, Seiji Futagami, Yasuhiro Takahashi, Hitoshi Takano & Choitsu Sakamoto. (2015) Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease. Digestive and Liver Disease 47:9, pages 757-762.
Crossref
Crossref
Hiroki Endo, Eiji Sakai, Takayuki Kato, Shotaro Umezawa, Takuma Higurashi, Hidenori Ohkubo & Atsushi Nakajima. (2014) Small bowel injury in low-dose aspirin users. Journal of Gastroenterology 50:4, pages 378-386.
Crossref
Crossref
Mitsuhiro Fujishiro, Kazuhide Higuchi, Mototsugu Kato, Yoshikazu Kinoshita, Ryuichi Iwakiri, Toshio Watanabe, Toshihisa Takeuchi, Nobuyuki SugisakiYasushi Okada, Hisao Ogawa, Tetsuo Arakawa & Kazuma Fujimoto. (2015) Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial. Journal of Clinical Biochemistry and Nutrition 56:3, pages 228-239.
Crossref
Crossref
Hiroki Endo, Eiji Sakai, Leo Taniguchi, Takaomi Kessoku, Yasuhiko Komiya, Akiko Ezuka, Harunobu Kawamura, Masataka Taguri, Takuma Higurashi, Hidenori Ohkubo, Eiji Yamada, Hirokazu Takahashi, Masahiko Inamori, Shin Maeda, Takashi Sakaguchi, Yasuo Hata, Hajime Nagase & Atsushi Nakajima. (2014) Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry. Gastrointestinal Endoscopy 80:5, pages 826-834.
Crossref
Crossref
R. Iwakiri, K. Higuchi, M. Kato, M. Fujishiro, Y. Kinoshita, T. Watanabe, T. Takeuchi, M. Yamauchi, M. Sanomura, H. Nakagawa, N. Sugisaki, Y. Okada, H. Ogawa, T. Arakawa & K. Fujimoto. (2014) Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low‐dose aspirin. Alimentary Pharmacology & Therapeutics 40:7, pages 780-795.
Crossref
Crossref
Gwen M.C. Masclee, Vera E. Valkhoff, Preciosa M. Coloma, Maria de Ridder, Silvana Romio, Martijn J. Schuemie, Ron Herings, Rosa Gini, Giampiero Mazzaglia, Gino Picelli, Lorenza Scotti, Lars Pedersen, Ernst J. Kuipers, Johan van der Lei & Miriam C.J.M. Sturkenboom. (2014) Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations. Gastroenterology 147:4, pages 784-792.e9.
Crossref
Crossref
Kentaro Sugano, Myung-Gyu Choi, Jaw-Town Lin, Shinya Goto, Yasushi Okada, Yoshikazu Kinoshita, Hiroto Miwa, Chern-En Chiang, Tsutomu Chiba, Masatsugu Hori, Yasushi Fukushima, Hyun-Soo Kim, Chi-Yang Chang & Masataka Date. (2014) Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study. Gut 63:7, pages 1061-1068.
Crossref
Crossref
Naomi Uemura, Kentaro Sugano, Hideyuki Hiraishi, Kazuyuki Shimada, Shinya Goto, Shinichiro Uchiyama, Yasushi Okada, Hideki Origasa & Yasuo Ikeda. (2013) Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. Journal of Gastroenterology 49:5, pages 814-824.
Crossref
Crossref
Gwen M. C. Masclee, Miriam C. J. M. Sturkenboom & Ernst J. Kuipers. (2014) A Benefit–Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly. Drugs & Aging 31:4, pages 263-282.
Crossref
Crossref
Nicolette L. de Groot, Matthijs P. Hagenaars, Hugo M. Smeets, Ewout W. Steyerberg, Peter D. Siersema & Martijn G. H. van Oijen. (2013) Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts. Journal of Gastroenterology 49:2, pages 245-253.
Crossref
Crossref
Wen-Chi Chen, Yun-Da Li, Po-Hung Chiang, Feng-Woei Tsay, Hoi-Hung Chan, Wei-Lun Tsai, Tzung-Jiun Tsai, E-Ming Wang, Jin-Shiung Cheng & Kwok-Hung Lai. (2014) Comparison of Proton Pump Inhibitor and Histamine-2 Receptor Antagonist in the Prevention of Recurrent Peptic Ulcers/Erosions in Long-Term Low-Dose Aspirin Users: A Retrospective Cohort Study. BioMed Research International 2014, pages 1-7.
Crossref
Crossref
Pin-Yao Wang, Hsiu-Ping Chen, Angela Chen, Feng-Woei Tsay, Kwok-Hung Lai, Sung-Shuo Kao, Wen-Chi Chen, Chao-Hung Kuo, Nan-Jing Peng, Hui-Hwa Tseng & Ping-I Hsu. (2014)
Impact of Blood Type, Functional Polymorphism (T-1676C) of the
COX-1
Gene Promoter and Clinical Factors on the Development of Peptic Ulcer during Cardiovascular Prophylaxis with Low-Dose Aspirin
. BioMed Research International 2014, pages 1-6.
Crossref
Crossref
C.-C. Lin, H.-Y. Hu, J.-C. Luo, Y.-L. Peng, M.-C. Hou, H.-C. Lin & F.-Y. Lee. (2013) Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study. Alimentary Pharmacology & Therapeutics 38:9, pages 1119-1128.
Crossref
Crossref
J. Hedberg, J. Sundström, M. Thuresson, P. Aarskog, J. Oldgren & J. Bodegard. (2013) Low‐dose acetylsalicylic acid and gastrointestinal ulcers or bleeding – a cohort study of the effects of proton pump inhibitor use patterns. Journal of Internal Medicine 274:4, pages 371-380.
Crossref
Crossref
Hiroshi Satoh, Kikuko Amagase & Koji Takeuchi. (2013) The Role of Food for the Formation and Prevention of Gastrointestinal Lesions Induced by Aspirin in Cats. Digestive Diseases and Sciences 58:10, pages 2840-2849.
Crossref
Crossref
Tsuyoshi Fujita, Hiromu Kutsumi, Tsuyoshi Sanuki, Takanobu Hayakumo & Takeshi Azuma. (2013) Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries. Journal of Gastroenterology 48:5, pages 559-573.
Crossref
Crossref
Luiz Gonzaga Coelho, Ismael Maguinilk, Schlioma Zaterka, José Miguel Parente, Maria do Carmo Friche Passos & Joaquim Prado P. Moraes-Filho. (2013) 3rd BRAZILIAN CONSENSUS ON Helicobacter pylori. Arquivos de Gastroenterologia 50:2, pages 81-96.
Crossref
Crossref
Sinthiya Punnialingam & Munther A. Khamashta. (2013) Duration of Anticoagulation Treatment for Thrombosis in APS: Is It Ever Safe to Stop?. Current Rheumatology Reports 15:4.
Crossref
Crossref
James M. Scheiman, Johan Herlitz, Sander J. Veldhuyzen van Zanten, Angel Lanas, Stefan Agewall, Emma C. Nauclér, Lars-Erik Svedberg & Péter Nagy. (2013) Esomeprazole for Prevention and Resolution of Upper Gastrointestinal Symptoms in Patients Treated With Low-dose Acetylsalicylic Acid for Cardiovascular Protection. Journal of Cardiovascular Pharmacology 61:3, pages 250-257.
Crossref
Crossref
Prarthana Thiagarajan & Janusz A. Jankowski. (2013) Tipping the Balance: Benefits and Risks of Aspirin in Chemoprevention of Colorectal Cancer. Current Colorectal Cancer Reports 9:1, pages 1-8.
Crossref
Crossref
Peter Bytzer, Stephen Pratt, Eric Elkin, Jørgen Næsdal & Elisabeth Sörstadius. (2012) Burden of Upper Gastrointestinal Symptoms in Patients Receiving Low-Dose Acetylsalicylic Acid for Cardiovascular Risk Management. American Journal of Cardiovascular Drugs 13:1, pages 27-35.
Crossref
Crossref
Kazumasa Miyake, Masafumi Kusunoki, Nobue Ueki, Hiroyuki Nagoya, Yasuhiro Kodaka, Tomotaka Shindo, Tetsuro Kawagoe, Katya Gudis, Seiji Futagami, Taku Tsukui, Hiroshi Nakamura & Choitsu Sakamoto. (2012) Implication of antithrombotic agents on potential bleeding from endoscopically determined peptic ulcers, incidentally detected as surrogate markers for nsaids‐associated ulcers complication. Digestive Endoscopy 25:1, pages 25-31.
Crossref
Crossref
Luis A. Garcia Rodriguez, Lucia Cea-Soriano, Stefania Tacconelli & Paola Patrignani. 2013. Prospects for Chemoprevention of Colorectal Neoplasia. Prospects for Chemoprevention of Colorectal Neoplasia
67
93
.
Tsuyoshi Sanuki, Tsuyoshi Fujita, Hiromu Kutsumi, Takanobu Hayakumo, Shun-ichi Yoshida, Hideto Inokuchi, Manabu Murakami, Yoshihiro Matsubara, Hajime Kuwayama, Takashi Kawai, Hideki Miyaji, Takashi Fujisawa, Shuichi Terao, Yukinao Yamazaki & Takeshi Azuma. (2012) Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. Journal of Gastroenterology 47:11, pages 1186-1197.
Crossref
Crossref
Sashwati Roy, Debasis Bagchi & Siba RaychaudhuriAlakendu Ghosh & Pradyot Sinhamahapatra. 2012. Chronic Inflammation. Chronic Inflammation
407
422
.
R. Agha & M. Agha. (2011) Severe occult upper gastrointestinal haemorrhage. QJM 105:7, pages 679-681.
Crossref
Crossref
Chun-Peng Liu, Wen-Chi Chen, Kwok-Hung Lai, Guang-Yuan Mar, Shyr-Yi Lin, Luo-Ping Ger & Ping-I Hsu. (2012) Esomeprazole Alone Compared with Esomeprazole Plus Aspirin for the Treatment of Aspirin-Related Peptic Ulcers. American Journal of Gastroenterology 107:7, pages 1022-1029.
Crossref
Crossref
Francis Ka–leung Chan, Shinya Goto, Ming–Shiang Wu, Maria Teresa B. Abola, Khay Guan Yeoh, Bambang Sutrisna, Siew Siang Chua, Varocha Mahachai, Thana Turajane, Brian Wu, Qing Yu Zeng & Kentaro Sugano. (2012) Burden of Nonsteroidal Anti-inflammatory and Antiplatelet Drug Use in Asia: A Multidisciplinary Working Party Report. Clinical Gastroenterology and Hepatology 10:7, pages 753-760.
Crossref
Crossref
Katherine A. Lyseng-Williamson, Celeste B. Burness & Lesley J. Scott. (2012) Fixed-dose acetylsalicylic acid/esomeprazole: a guide to its use to prevent cardiovascular events and reduce peptic ulcer risk. Drugs & Therapy Perspectives 28:6, pages 10-14.
Crossref
Crossref
Hideyuki Hiraishi, Ryo Oki, Kohei Tsuchida, Naoto Yoshitake, Keiichi Tominaga, Koji Kusano, Takashi Hashimoto, Mitsunori Maeda, Takako Sasai & Tadahito Shimada. (2012) Frequency of nonsteroidal anti-inflammatory drug-associated ulcers. Clinical Journal of Gastroenterology 5:3, pages 171-176.
Crossref
Crossref
Rubén Casado-Arroyo, Carla Gargallo & Ángel Lanas Arbeloa. (2012) Balancing the risk and benefits of low-dose aspirin in clinical practice. Best Practice & Research Clinical Gastroenterology 26:2, pages 173-184.
Crossref
Crossref
Rubén Casado-Arroyo, Fatih Bayrak, Andrea Sarkozy, Gian-Battista Chierchia, Carlo de Asmundis & Pedro Brugada. (2012) Role of ASA in the primary and secondary prevention of cardiovascular events. Best Practice & Research Clinical Gastroenterology 26:2, pages 113-123.
Crossref
Crossref
Vera E. Valkhoff, Miriam C.J.M. Sturkenboom & Ernst J. Kuipers. (2012) Risk factors for gastrointestinal bleeding associated with low-dose aspirin. Best Practice & Research Clinical Gastroenterology 26:2, pages 125-140.
Crossref
Crossref
En-ling Leung Ki & Francis K.L. Chan. (2012) Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: Implications for clinical practice. Best Practice & Research Clinical Gastroenterology 26:2, pages 163-172.
Crossref
Crossref
Celeste B. Burness & Lesley J. Scott. (2012) Acetylsalicylic Acid/Esomeprazole Fixed-Dose Combination. Drugs & Aging 29:3, pages 233-242.
Crossref
Crossref
C. Hiew, A. Duggan, T. de Malmanche, R. Hatton, F. Baker, J. Attia & N. Collins. (2012)
Prevalence of
Helicobacter pylori
positivity in patients undergoing percutaneous coronary intervention
. Internal Medicine Journal 42:3, pages 289-293.
Crossref
Crossref
Masaki Miyamoto, Ken Haruma, Takeshi Okamoto, Yuusuke Higashi, Toru Hidaka & Noriaki Manabe. (2012) Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan. Journal of Gastroenterology and Hepatology 27:2, pages 372-377.
Crossref
Crossref
Rahel Häuptle, Daniel Weilenmann, Tino Schneider, Sarah R. Haile, Peter Ammann, Christina Knellwolf & Jan Borovicka. (2012) Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort studyIndividualisierte Protonenpumpeninhibitor (PPI)-Gabe bei Patienten mit kombinierter Thrombozytenaggregationshemmung (Aspirin und Clopidogrel) und unerwünschten gastrointestinalen Ereignissen nach perkutaner koronarer Intervention (PCI): Eine Kohortenstudie. Wiener Medizinische Wochenschrift 162:3-4, pages 67-73.
Crossref
Crossref
Alessandro Filippi, Cosetta Bianchi, Fabio Parazzini, Claudio Cricelli, Emiliano Sessa & Giampiero Mazzaglia. (2011) A national survey on aspirin patterns of use and persistence in community outpatients in Italy. European Journal of Cardiovascular Prevention & Rehabilitation 18:5, pages 695-703.
Crossref
Crossref
Wadie I. Najm. (2011) Peptic Ulcer Disease. Primary Care: Clinics in Office Practice 38:3, pages 383-394.
Crossref
Crossref
Carlos Sostres & Angel Lanas. (2011) Gastrointestinal effects of aspirin. Nature Reviews Gastroenterology & Hepatology 8:7, pages 385-394.
Crossref
Crossref
Janusz A. Jankowski & Patricia A. Hooper. (2011) Chemoprevention in Barrett's Esophagus: A Pill a Day?. Gastrointestinal Endoscopy Clinics of North America 21:1, pages 155-170.
Crossref
Crossref
Maddalena Lettino. (2010) Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: Facts or fancies?. European Journal of Internal Medicine 21:6, pages 484-489.
Crossref
Crossref
E. H. Fletcher, D. E. Johnston, C. R. Fisher, R. J. Koerner, J. L. Newton & C. S. Gray. (2010)
Systematic review:
Helicobacter pylori
and the risk of upper gastrointestinal bleeding risk in patients taking aspirin
. Alimentary Pharmacology & Therapeutics 32:7, pages 831-839.
Crossref
Crossref
Donald J. AbrahamSamuel Chackalamannil. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
409
476
.
R. Casado‐Arroyo, J. M. Scheiman, M. Polo‐Tomas, S. D. Saini, A. Del Rio, E. Guastello & A. Lanas. (2010) Underutilization of gastroprotection for at‐risk patients undergoing percutaneous coronary intervention: Spain compared with the United States. Alimentary Pharmacology & Therapeutics 32:5, pages 689-695.
Crossref
Crossref
Junichi Iwamoto, Yuji Mizokami, Koichi Shimokobe, Masanori Ito, Takeshi Hirayama, Yoshifumi Saito, Tadashi Ikegami, Akira Honda & Yasushi Matsuzaki. (2009) Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin. Digestive Diseases and Sciences 55:8, pages 2270-2274.
Crossref
Crossref
Kenichi Nonoyama, Kanako Nakagawa, Kikuko Amagase, Koji Takeuchi, Masahiko Nakamura & Susumu Okabe. (2010) New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin. Journal of Gastroenterology and Hepatology 25, pages S15-S22.
Crossref
Crossref
Johan Herlitz, Peter P. Tóth & Jørgen Næsdal. (2010) Low-Dose Aspirin Therapy for Cardiovascular Prevention. American Journal Cardiovascular Drugs 10:2, pages 125-141.
Crossref
Crossref
Carlos Sostres, Carla J. Gargallo, Maria T. Arroyo & Angel Lanas. (2010) Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Practice & Research Clinical Gastroenterology 24:2, pages 121-132.
Crossref
Crossref
John L Wallace, Giuseppe Caliendo, Vincenzo Santagada & Giuseppe Cirino. (2010) Markedly reduced toxicity of a hydrogen sulphide‐releasing derivative of naproxen (ATB‐346). British Journal of Pharmacology 159:6, pages 1236-1246.
Crossref
Crossref
Randall W. Lengeling & Konrad S. Schulze. (2010) Comments on Nonsteroidal Anti-Inflammatory Drug Enteropathy. Clinical Gastroenterology and Hepatology 8:2, pages 223-224.
Crossref
Crossref
Isamu Tamura, Tsuyoshi Fujita, Hidetaka Tsumura, Yoshinori Morita, Masaru Yoshida, Takashi Toyonaga, Seiichi Hirano, Hideto Inokuchi, Hiromu Kutsumi & Takeshi Azuma. (2010) Low-Dose Aspirin-Induced Gastroduodenal Mucosal Injury in Japanese Patients with Arteriosclerotic Disease. Internal Medicine 49:23, pages 2537-2545.
Crossref
Crossref
Angel Lanas. (2010) Inhibidores de la bomba de protones y clopidogrel en el paciente cardiovascular: ¿riesgo cardiovascular versus riesgo gastrointestinal?. Gastroenterología y Hepatología 33:1, pages 1-5.
Crossref
Crossref
Carlos Sostres, Carla Gargallo & Angel Lanas. (2009) Drug-related damage of the ageing gastrointestinal tract. Best Practice & Research Clinical Gastroenterology 23:6, pages 849-860.
Crossref
Crossref
K Ming Fock, Peter Katelaris, Kentaro Sugano, Tiing Leong Ang, Richard Hunt, Nicholas J Talley, Shiu Kum Lam, Shu-Dong Xiao, Huck Joo Tan, Chun-Ying Wu, Hyun Chae Jung, Bui Huu Hoang, Udom Kachintorn, Khean-Lee Goh, Tsutomu Chiba & Abdul Aziz Rani. (2009)
Second Asia-Pacific Consensus Guidelines for
Helicobacter pylori
infection
. Journal of Gastroenterology and Hepatology 24:10, pages 1587-1600.
Crossref
Crossref
Peter Malfertheiner, Francis KL Chan & Kenneth EL McColl. (2009) Peptic ulcer disease. The Lancet 374:9699, pages 1449-1461.
Crossref
Crossref
Janusz Jankowski, Stephen Attwood, John deCaestecker & Hugh Barr. (2009) Aspirin in the primary prevention of vascular disease. The Lancet 374:9693, pages 877-878.
Crossref
Crossref
Masayuki Nakayama, Ryuichi Iwakiri, Megumi Hara, Hibiki Ootani, Ryo Shimoda, Seiji Tsunada, Hiroyuki Sakata & Kazuma Fujimoto. (2009) Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. Journal of Gastroenterology 44:9, pages 912-918.
Crossref
Crossref
S. I. Al-Azzam, F. AlMahasneh, N. Mhaidat, K. H. Alzoubi & Y. S. Khader. (2009) Prophylactic use of aspirin does not induce anaemia among adults. Journal of Clinical Pharmacy and Therapeutics.
Crossref
Crossref
Jiing-Chyuan Luo. (2009) Gastroprotective Strategy in Aspirin Users. Journal of the Chinese Medical Association 72:7, pages 343-345.
Crossref
Crossref
Byron Cryer. (2009) Management of Patients with High Gastrointestinal Risk on Antiplatelet Therapy. Gastroenterology Clinics of North America 38:2, pages 289-303.
Crossref
Crossref
Edgardo Smecuol, Maria Ines Pinto Sanchez, Alejandro Suarez, Julio E. Argonz, Emilia Sugai, Horacio Vazquez, Nestor Litwin, Elena Piazuelo, Jonathan B. Meddings, Julio C. Bai & Angel Lanas. (2009) Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment. Clinical Gastroenterology and Hepatology 7:5, pages 524-529.
Crossref
Crossref
Rosa Madridejos Mora & Eva Llobet Traveset. (2009) Indicaciones para la gastroprotección. FMC - Formación Médica Continuada en Atención Primaria 16:5, pages 294-298.
Crossref
Crossref
L. Björklund, M.-A. Wallander, S. Johansson & E. Lesén. (2009) Aspirin in cardiology - benefits and risks. International Journal of Clinical Practice 63:3, pages 468-477.
Crossref
Crossref
Kay Brune, Burkhard Hinz & Ivan Otterness. (2009) Aspirin and acetaminophen: Should they be available over the counter?. Current Rheumatology Reports 11:1, pages 36-40.
Crossref
Crossref
Takashi Kawai, Tetsuya Yamagishi & Shinya Goto Shinya Goto. (2009) Circadian Variations of Gastrointestinal Mucosal Damage Detected with Transnasal Endoscopy in Apparently Healthy Subjects Treated with Low-Dose Aspirin (ASA) for a Short Period. Journal of Atherosclerosis and Thrombosis 16:3, pages 155-163.
Crossref
Crossref
Shohei Shimizu, Shinichi Nakamura, Maiko Kishino, Hiroyuki Konishi & Keiko Shiratori. (2009) Role of Antithrombotic Therapy and Nonsteroidal Anti-inflammatory Drug Use in Bleeding Gastroduodenal Ulcers. Internal Medicine 48:9, pages 631-637.
Crossref
Crossref
K. Schimke, S. A. P. Chubb, W. A. Davis, P. Phillips & T. M. E. Davis. (2009)
Antiplatelet therapy,
Helicobacter pylori
infection and complicated peptic ulcer disease in diabetes: The Fremantle Diabetes Study
. Diabetic Medicine 26:1, pages 70-75.
Crossref
Crossref
Henning Schröder. (2009) Nitric Oxide and Aspirin: A New Mediator for an Old Drug. American Journal of Therapeutics 16:1, pages 17-23.
Crossref
Crossref
A Mark Fendrick, Deborah E Pan & Grace E Johnson. (2008) OTC analgesics and drug interactions: clinical implications. Osteopathic Medicine and Primary Care 2:1.
Crossref
Crossref
Deepak L. Bhatt, James Scheiman, Neena S. Abraham, Elliott M. Antman, Francis K.L. Chan, Curt D. Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M. Quigley, Robert A. Harrington, Eric R. Bates, Charles R. Bridges, Mark J. Eisenberg, Victor A. Ferrari, Mark A. Hlatky, Sanjay Kaul, Jonathan R. Lindner, David J. Moliterno, Debabrata Mukherjee, Richard S. Schofield, Robert S. Rosenson, James H. Stein, Howard H. Weitz & Deborah J. Wesley. (2008) ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use. The American Journal of Gastroenterology 103:11, pages 2890-2907.
Crossref
Crossref
Deepak L. Bhatt, James Scheiman, Neena S. Abraham, Elliott M. Antman, Francis K.L. Chan, Curt D. Furberg, David A. Johnson, Kenneth W. Mahaffey & Eamonn M. Quigley. (2008) ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use. Circulation 118:18, pages 1894-1909.
Crossref
Crossref
Neville Yeomans, Angel Lanas, Joachim Labenz, Sander Veldhuyzen van Zanten, Christoffel van Rensburg, Istvan Rácz, Konstantin Tchernev, Dimitrios Karamanolis, Enrico Roda, Chris Hawkey, Emma Nauclér & Lars-Erik Svedberg. (2008) Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated With Continuous Use of Low-Dose Aspirin. The American Journal of Gastroenterology 103:10, pages 2465-2473.
Crossref
Crossref
Deepak L. Bhatt, James Scheiman, Neena S. Abraham, Elliott M. Antman, Francis K.L. Chan, Curt D. Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M. Quigley, Robert A. Harrington, Eric R. Bates, Charles R. Bridges, Mark J. Eisenberg, Victor A. Ferrari, Mark A. Hlatky, Sanjay Kaul, Jonathan R. Lindner, David J. Moliterno, Debabrata Mukherjee, Richard S. Schofield, Robert S. Rosenson, James H. Stein, Howard H. Weitz & Deborah J. Wesley. (2008) ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use. Journal of the American College of Cardiology 52:18, pages 1502-1517.
Crossref
Crossref
Shaojun Shi & Ulrich Klotz. (2008) Proton pump inhibitors: an update of their clinical use and pharmacokinetics. European Journal of Clinical Pharmacology 64:10, pages 935-951.
Crossref
Crossref
Chang Kyu Choi, Nayoung Kim, Jin Woo Choi, Young Soo Park, Jin-Wook Kim, Sook-Hyang Jeong, Dong Ho Lee, Young-Seok Cho, Tae-Jin Youn, Woo-Young Chung, In-Ho Chae & Dong-Ju Choi. (2008) Effect of Low-dose, Enteric Coated Aspirin on Gastrointestinal Bleeding in Patients with Coronary Artery Disease. Gut and Liver 2:2, pages 99-104.
Crossref
Crossref
Stephen E.A. Attwood & Christopher A. Lamb. (2008) Eosinophilic oesophagitis and other non-reflux inflammatory conditions of the oesophagus: Diagnostic imaging and management. Best Practice & Research Clinical Gastroenterology 22:4, pages 639-660.
Crossref
Crossref
L. E. TARGOWNIK, C. J. METGE & S. LEUNG. (2008) Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications. Alimentary Pharmacology & Therapeutics 28:1, pages 88-96.
Crossref
Crossref
Ryuichi Iwakiri & Kazuma Fujimoto. (2008) Roles of NSAIDs and aspirin in bleeding peptic ulcers. Clinical Journal of Gastroenterology 1:2, pages 33-39.
Crossref
Crossref
S. Balakrishnan & R. Jhaj. (2008) Prophylactic use of gastro-protective agents in patients on low-dose aspirin. British Journal of Clinical Pharmacology 65:4, pages 621-622.
Crossref
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:8, pages i-xii.
Crossref
Crossref
James E Frampton & Gillian M Keating. (2007) Celecoxib. Drugs 67:16, pages 2433-2472.
Crossref
Crossref